Verification of proposed peripheral biomarkers in mononuclear cells of individuals with schizophrenia

Journal of Psychiatric Research

Volumn 42, Issue 8, 2008, Pages 639-643

  Yao, Yuanrong ^a   Schröder, Johannes ^b   Karlsson, Håkan ^c  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Blood; CXCL1; Expression; Gene; Real time PCR; Schizophrenia

Indexed keywords

BENPERIDOL; BIOLOGICAL MARKER; CALGRANULIN B; CXCL1 CHEMOKINE; HALOPERIDOL; OLANZAPINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HOSPITAL PATIENT; HUMAN; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SCHIZOPHRENIA;

ANTIPSYCHOTIC AGENTS; BIOLOGICAL MARKERS; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; LEUKOCYTES, MONONUCLEAR; SCHIZOPHRENIA;

EID: 43049142299     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2007.07.011     Document Type: Article

References (19)

1. Aravalli R.N., Hu S., Rowen T.N., Palmquist J.M., and Lokensgard J.R. Cutting edge: TLR2-mediated proinflammatory cytokine and chemokine production by microglial cells in response to herpes simplex virus. Journal of Immunology 175 (2005) 4189-4193
2. Bowden N.A., Weidenhofer J., Scott R.J., Schall U., Todd J., Michie P.T., et al. Preliminary investigation of gene expression profiles in peripheral blood lymphocytes in schizophrenia. Schizophrenia Research 82 (2006) 175-183
3. Glatt S.J., Everall I.P., Kremen W.S., Corbeil J., Sasik R., Khanlou N., et al. Comparative gene expression analysis of blood and brain provides concurrent validation of SELENBP1 up-regulation in schizophrenia. Proceedings of the National Academy of Sciences USA 102 (2005) 15533-15538
4. Häfner H., and Löffler W. IRAOS: interview for the retrospective assessment of the onset and course of schizophrenia and other psychoses (2003), Hogrefe & Hubert, Toronto
5. Holmes R.K., Malim M.H., and Bishop K.N. APOBEC-mediated viral restriction: not simply editing?. Trends in Biochemical Sciences 32 (2007) 118-128
6. Kay S.R., Fiszbein A., and Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin 13 (1987) 261-276
7. Konig A., Krenn V., Toksoy A., Gerhard N., and Gillitzer R. Mig, GRO alpha and RANTES messenger RNA expression in lining layer, infiltrates and different leucocyte populations of synovial tissue from patients with rheumatoid arthritis, psoriatic arthritis and osteoarthritis. Virchows Archiv 436 (2000) 449-458
8. Lane B.R., Strieter R.M., Coffey M.J., and Markovitz D.M. Human immunodeficiency virus type 1 (HIV-1)-induced GRO-alpha production stimulates HIV-1 replication in macrophages and T lymphocytes. Journal of Virology 75 (2001) 5812-5822
9. Lee Y.N., and Bieniasz P.D. Reconstitution of an infectious human endogenous retrovirus. PLoS Pathogens 3 (2007) e10
10. Middleton F.A., Pato C.N., Gentile K.L., McGann L., Brown A.M., Trauzzi M., et al. Gene expression analysis of peripheral blood leukocytes from discordant sib-pairs with schizophrenia and bipolar disorder reveals points of convergence between genetic and functional genomic approaches. Americal Journal of Medical Genetics Part B Neuropsychiatric Genetics 136 (2005) 12-25
11. Moser B., Clark-Lewis I., Zwahlen R., and Baggiolini M. Neutrophil-activating properties of the melanoma growth-stimulatory activity. Journal of Experimental Medicine 171 (1990) 1797-1802
12. Nellaker C., Yao Y., Jones-Brando L., Mallet F., Yolken R.H., and Karlsson H. Transactivation of elements in the human endogenous retrovirus W family by viral infection. Retrovirology 3 (2006) 44
13. Strauss J.S., and Carpenter Jr. W.T. The prediction of outcome in schizophrenia. II. Relationships between predictor and outcome variables: a report from the WHO international pilot study of schizophrenia. Archives of General Psychiatry 31 (1974) 37-42
14. Sullivan P.F., Fan C., and Perou C.M. Evaluating the comparability of gene expression in blood and brain. American Journal of Medical Genetics Part B Neuropsychiatric Genetics 141 (2006) 261-268
15. Tsai H.H., Frost E., To V., Robinson S., Ffrench-Constant C., Geertman R., et al. The chemokine receptor CXCR2 controls positioning of oligodendrocyte precursors in developing spinal cord by arresting their migration. Cell 110 (2002) 373-383
16. Tsuang M.T., Nossova N., Yager T., Tsuang M.M., Guo S.C., Shyu K.G., et al. Assessing the validity of blood-based gene expression profiles for the classification of schizophrenia and bipolar disorder: a preliminary report. American Journal of Medical Genetics Part B Neuropsychiatric Genetics 133 (2005) 1-5
17. Vawter M.P., Ferran E., Galke B., Cooper K., Bunney W.E., and Byerley W. Microarray screening of lymphocyte gene expression differences in a multiplex schizophrenia pedigree. Schizophrenia Research 67 (2004) 41-52
18. Wittchen H.U., Wunderlich U., Gruschwitz S., and Zaudig M. SKID-I. Strukturiertes klinisches interview fur DSM-IV (1997), Hogrefe, Göttingen
19. Zvara A., Szekeres G., Janka Z., Kelemen J.Z., Cimmer C., Santha M., et al. Over-expression of dopamine D2 receptor and inwardly rectifying potassium channel genes in drug-naive schizophrenic peripheral blood lymphocytes as potential diagnostic markers. Disease Markers 21 (2005) 61-69